透過您的圖書館登入
IP:44.211.239.181
  • 期刊

過敏性鼻炎Rinderon鼻內及肌內注射之比較

Comparison of Effects of Intranasal and Intramuscular Rinderon Injection for Allergic Rhinitis

摘要


Background and Purpose: The goal of the study is to compare the efficacy of single Rinderon(superscript ®) injection between intranasal route and intramuscular route. Methods: From January 2005 to December 2006, forty volunteers from outpatients were enrolled into the study. They were all diagnosed as allergic rhinitis without any other underlying disease, randomly categorized into two groups: intranasal injection group or intramuscular injection group, with 20 patients in each. A dosage of 25mg Rinderon(superscript ®) in liquid form was injected to each subject via different route according to the group he/she was in, at one week after cessation of any medication for allergic rhinitis. Serum cortisol level was measured before and at 2 weeks, 4 weeks after injection. The questionnaire of symptoms and nasal mucosa biopsy were obtained before and at 4 weeks after injection to identify the effect. Results: In intranasal injection group, 15 (75%) patients had significant symptomatic improvement, whereas in intramuscular injection group, 11 (55%) patients significantly improved. The difference between 2 groups was measured by Chi-square method and showed no significant difference (P value>0.05). The depression of serum cortisol level was statistically significant in each group at 2 weeks, 4 weeks after the injection, compared to their pre-injection level (p<0.05, all). However, the depression level between 2 groups does not significantly differ (p>0.05). Even the serum cortisol level was significantly depressed after the injection in both groups, the value was still within the normal fluctuation rang, and afterward returned to normal level no later than 4 weeks. The rebound phenomenon of serum cortisol level after iatrogenic depression measured at 1 month after injection revealed no significant difference between the two groups (p>0.05). Conclusion: In addition to the given routes of oral intake, nasal spray, and intramuscular injection, intranasal injection of single dose steroid is also an effective and safe modality in the treatment of allergic rhinitis.

並列摘要


Background and Purpose: The goal of the study is to compare the efficacy of single Rinderon(superscript ®) injection between intranasal route and intramuscular route. Methods: From January 2005 to December 2006, forty volunteers from outpatients were enrolled into the study. They were all diagnosed as allergic rhinitis without any other underlying disease, randomly categorized into two groups: intranasal injection group or intramuscular injection group, with 20 patients in each. A dosage of 25mg Rinderon(superscript ®) in liquid form was injected to each subject via different route according to the group he/she was in, at one week after cessation of any medication for allergic rhinitis. Serum cortisol level was measured before and at 2 weeks, 4 weeks after injection. The questionnaire of symptoms and nasal mucosa biopsy were obtained before and at 4 weeks after injection to identify the effect. Results: In intranasal injection group, 15 (75%) patients had significant symptomatic improvement, whereas in intramuscular injection group, 11 (55%) patients significantly improved. The difference between 2 groups was measured by Chi-square method and showed no significant difference (P value>0.05). The depression of serum cortisol level was statistically significant in each group at 2 weeks, 4 weeks after the injection, compared to their pre-injection level (p<0.05, all). However, the depression level between 2 groups does not significantly differ (p>0.05). Even the serum cortisol level was significantly depressed after the injection in both groups, the value was still within the normal fluctuation rang, and afterward returned to normal level no later than 4 weeks. The rebound phenomenon of serum cortisol level after iatrogenic depression measured at 1 month after injection revealed no significant difference between the two groups (p>0.05). Conclusion: In addition to the given routes of oral intake, nasal spray, and intramuscular injection, intranasal injection of single dose steroid is also an effective and safe modality in the treatment of allergic rhinitis.

被引用紀錄


張翠如、陳玉麗、楊惠晶、陳麗琴、何昭中、王琤(2019)。慢性過敏性鼻炎患者接受三伏貼療法之生活品質及症狀改變歷程志為護理-慈濟護理雜誌18(3),67-79。https://www.airitilibrary.com/Article/Detail?DocID=16831624-201906-201906270010-201906270010-67-79

延伸閱讀